Skip to content

IMNN

Imunon, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.58
+1.28%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue500.0K
Cost of Revenue166.5K
Gross Profit(166.5K)500.0K
Operating Expenses
R&D Expense8.2M7.8M11.6M11.3M11.7M
SG&A Expense2.0B6.9M7.5M9.7M13.7M
General & Admin Expense2.0B6.9M7.5M9.7M13.7M
Selling & Marketing Expense
Other Expenses(2.0B)
Total Operating Expenses14.7M14.7M19.1M21.0M25.4M
Cost and Expenses14.8M14.7M19.1M21.0M25.4M
Operating Income (EBIT)(14.8M)(14.7M)(19.1M)(21.0M)(24.9M)
Non-Operating
Interest Income175.6K155.7K450.2K725.8K502.6K
Interest Expense77.3K197.1K5.0M
Net Interest Income98.3K155.7K450.2K528.7K(4.5M)
Other Non-Op Income/Expense120.5K155.7K512.2K235.1K(12.5M)
Non-Operating Income (excl Interest)(197.8K)(155.7K)(512.2K)(432.1K)7.5M
EBT (Pre-Tax Income)(14.7M)(14.5M)(18.6M)(20.8M)(37.5M)
Income Tax Expense(1.3M)(1.6M)
Bottom Line
Net Income(14.7M)(14.5M)(18.6M)(19.5M)(35.9M)
Earnings from Cont. Ops(14.7M)(14.5M)(18.6M)(19.5M)(35.9M)
Earnings from Discont. Ops
Bottom Line Net Income(14.7M)(14.5M)(18.6M)(19.5M)(35.9M)
Per Share
Basic EPS($4.53)($6.83)($21.10)($28.14)($65.55)
Diluted EPS($4.53)($6.83)($21.10)($28.14)($65.55)
Revenue Per Share$0.00$0.00$0.00$0.00$0.91
Shares
Basic Shares Outstanding5.2M2.1M882292693474547627
Diluted Shares Outstanding5.2M2.1M882292693474547627
Profitability Metrics
EBITDA(14.1M)(13.8M)(17.9M)(19.9M)(31.7M)
D&A572.8K698.9K718.1K720.0K731.6K
EBIT(14.6M)(14.5M)(18.6M)(20.6M)(32.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026